CIPLA ESCITALOPRAM escitalopram (as oxalate) 20 mg film coated tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

escitalopram oxalate, Quantity: 25.548 mg

MAH:

Cipla Australia Pty Ltd

INN:

escitalopram oxalate

pharmaceutical_form:

Tablet, film coated

composition:

Excipient Ingredients: croscarmellose sodium; maize starch; magnesium stearate; mannitol; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000

administration_route:

Oral

units_in_package:

28

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Treatment of major depression. ,Treatment of social anxiety disorder (social phobia). ,Treatment of generalised anxiety disorder. ,Treatment of obsessive-compulsive disorder.

leaflet_short:

Visual Identification: White, round, biconvex film coated,tablets with E20 debossed on one side,and break line on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

authorization_status:

Licence status A

authorization_date:

2014-11-07